LetterLetter
Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects
MOTOHISA YAMAMOTO, KEN-ICHI TAKANO and HIROKI TAKAHASHI
The Journal of Rheumatology September 2018, 45 (9) 1339-1340; DOI: https://doi.org/10.3899/jrheum.180163
MOTOHISA YAMAMOTO
Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine;
MD, PhDKEN-ICHI TAKANO
Department of Otolaryngology, Sapporo Medical University School of Medicine;
MD, PhDHIROKI TAKAHASHI
Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Sapporo, Japan. This work was supported by the Research on Measures for Intractable Diseases Project matching fund subsidy from the Ministry of Health, Labor, and Welfare, Japan, and the Japan Agency for Medical Research and Development.
MD, PhDREFERENCES
- 1.↵
- 2.↵
- Fragoulis GE,
- Moutsopoulos HM
- 3.↵
- Kamisawa T,
- Okasaki K,
- Kawa S,
- Ito T,
- Inui K,
- Irie H,
- et al;
- Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan
- 4.↵
- 5.↵
- 6.↵
- Duru N,
- van der Goes MC,
- Jacobs JW,
- Andrews T,
- Boers M,
- Buttgereit F,
- et al.
In this issue
The Journal of Rheumatology
Vol. 45, Issue 9
1 Sep 2018
Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects
MOTOHISA YAMAMOTO, KEN-ICHI TAKANO, HIROKI TAKAHASHI
The Journal of Rheumatology Sep 2018, 45 (9) 1339-1340; DOI: 10.3899/jrheum.180163